It is a pharma private limited company based in Varanasi, Uttar Pradesh, India, established in 2010.
2010 | Varanasi, Uttar Pradesh, India | ActiveBridge Formulation Private Limited, a active private limited company, was established on 27 July 2010 in Varanasi, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100UP2010PTC041468. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
Formerly known as Abhyudaya Educational Private Limited. It upholds a compliant status. Employing 7 professional, Its leadership includes Nirmal Jyoti (Director), Shailesh Chaubey (Director). Past directors included Pankaj Kumar Srivastava, Mukesh Singh, Umesh Singh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S-8/2A-4H, Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, 221002.
U24100UP2010PTC041468
041468
27 July 2010
₹2.50 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Bridge Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirmal Jyoti | Director | 10 May 2013 | Current |
| Shailesh Chaubey | Director | 03 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jun 2025 | Past |
| Pramod Abcsdd | Director | 30 Oct 2017 | Past |
| Pramod Abcsdd | Director | 01 Jul 2024 | Past |
| Pramod Abcsdd | Director | 01 Jul 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bridge Formulation Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.88% decrease. The company also saw a substantial fall in profitability, with a 8583.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 608.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Bridge Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Bridge Formulation has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bridge Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bridge Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shailesh Chaubey was appointed as a Director was appointed as a Director on 03 Jun 2025 & has been associated with this company since 5 months 24 days . was documented.
Progress on Bridge Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Bridge Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Nirmal Jyoti was appointed as a Director was appointed as a Director on 10 May 2013 & has been associated with this company since 12 years 6 months . was documented.
The activity Bridge Formulation Private Limited was registered on 27 Jul 2010 with Roc Kanpur & aged 15 years 4 months as per MCA records. was completed.
The CIN of Bridge Formulation Private Limited is U24100UP2010PTC041468.
Bridge Formulation Private Limited is headquartered at S-8/2A-4H, Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, 221002.
Bridge Formulation Private Limited was incorporated on 27 July 2010.
The current directors of Bridge Formulation Private Limited are
The primary industry of Bridge Formulation Private Limited is Trade.
Bridge Formulation Private Limited is unlisted.
The authorized capital of Bridge Formulation Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Bridge Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX